Search
  • Biohaven Pharmaceuticals

A Child's Migraine Affects The Whole Family

Migraine can take its toll on the whole family. Listen to Ethan's experience with migraine, and how it has affected him and the lives around him.


Biohaven Pharmaceuticals is studying an investigational drug, to potentially treat migraines in the pediatric population. If you or your child, between 12 and 18 years of age, suffer from migraine for at least 6 months you may qualify. Learn more about our pediatric migraine study.

Recent Posts

See All